A nano-enhanced vaccine for metastatic melanoma immunotherapy

Aim: Despite the huge advancements in cancer therapies and treatments over the past decade, most patients with metastasized melanoma still die from the disease. This poor prognosis largely results from resistance to conventional chemotherapies and other cytotoxic drugs. We have previously identified...

Descripción completa

Detalles Bibliográficos
Autores principales: Salotto, Katelyn E., Olson Jr, Walter C., Pollack, Karlyn E., Illendula, Anuradha, Michel, Elishama, Henriques, Sydney, Fox, Todd, Walker, Susan, Dunlap-Brown, Marya, Slingluff Jr, Craig L., Kester, Mark, Snyder, Helena W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511805/
https://www.ncbi.nlm.nih.gov/pubmed/36176766
http://dx.doi.org/10.20517/cdr.2021.132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511805/
https://www.ncbi.nlm.nih.gov/pubmed/36176766
http://dx.doi.org/10.20517/cdr.2021.132

Ejemplares similares